title: Two-year experience with FK 506 in pediatric patients.
authors.affiliation: Transplant Institute, University of Pittsburgh, PA 15213.
authors.forename: A G
authors.initials: AG
authors.lastname: Tzakis
authors.forename: J
authors.initials: J
authors.lastname: Reyes
authors.forename: S
authors.initials: S
authors.lastname: Todo
authors.forename: B
authors.initials: B
authors.lastname: Nour
authors.forename: R
authors.initials: R
authors.lastname: Shapiro
authors.forename: M
authors.initials: M
authors.lastname: Jordan
authors.forename: J
authors.initials: J
authors.lastname: McCauley
authors.forename: J
authors.initials: J
authors.lastname: Armitage
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D000293:Adolescent; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000009:adverse effects; D005500:Follow-Up Studies; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D007421:Intestine, Small / Q000637:transplantation; D016031:Liver Transplantation / Q000276:immunology*; D016040:Lung Transplantation / Q000276:immunology*; D008232:Lymphoproliferative Disorders / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D016019:Survival Analysis; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone; D016559:Tacrolimus